Clinical Trial Update: A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating TS-1 in combination with cisplatin for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• TS-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: TTY Biopharm | Conditions: Non-small-cell Lung Cancer (NSCLC) | NA | Status: COMPLETED